In the context of BRCA1- and BRCA2-derived cancers, other genes involved in high-volume DNA repair, or those key in other critical pathways whose functionality is required for cell survival and proliferation, are potential contenders for BRCA1/2 synthetic lethal partners (Figure 4). This evidence concerns the gene BRCA1 and cancer.